HEalth Advocate for Liver Transplant - Pilot
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Health Advocate.
- Who it may be relevant to
- Registry conditions: Liver Transplant; Complications, Pediatric ALL. Basic parameters: up to 17 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The Health Advocate for Liver Transplant (HEAL-Tx) Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for pediatric liver transplant patients and measure acceptability and feasibility according to RE-AIM.
Interventions
- Behavioral Health Advocate
The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.
Primary outcome measures
- Changes in caregiver experience [Time frame: Baseline and 90 days]
Secondary outcome measures (3)
- Change in medication adherence using MLVI [Time frame: Baseline, 90 days, and 180 days]
- The quality of health advocate interactions with the participants, healthcare team, and community-based resources. [Time frame: 90 days]
- A qualitative assessment of caregiver and healthcare provider satisfaction with the Health Advocate intervention. [Time frame: 90 days]
Eligibility criteria
Inclusion criteria
- Patients under 18 years if age that have undergone liver transplantation.
- Subject and/or parent/legal guardian can provide written informed consent and willing to comply with study procedures.
- Subject and/or parent/ legal guardian is willing to be contacted in the future by study staff.
- Patient and/or caregiver felt to be a good fit for this pilot by transplant team.
Exclusion criteria
- Caregiver unwilling or unable to complete the survey.
- Child is a ward of the state (e.g. foster care) since present circumstances may not be reflective of child's past or future circumstances.
- Non-English, non-Spanish speakers.
- Non-US residents.
- Greater than 18 years of age at the time of enrollment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
United States · 1 center
- University of California San Francisco — San Francisco
Identifiers
NCT: NCT05700799 · 22-36504 · K23DK132454